Fundamentals-based quality & risk · not a recommendation
Tata Chemicals Ltd scores 45/100 (Caution) on the Orion Score — weak business quality (42), poor growth (25), weak balance-sheet safety (41) and cheap valuation (86). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
39/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹3,438 | ₹-2,132 | -2.0% | ₹-83.68 |
| Q3 2026 | ₹3,550 | ₹-93 | 1.5% | ₹-3.65 |
| Q1 2026 | ₹3,719 | ₹252 | 9.9% | ₹9.89 |
| Q4 2025 | ₹3,509 | ₹-56 | 1.0% | ₹-2.19 |
| Q3 2025 | ₹3,590 | ₹-53 | 4.3% | ₹-2.08 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹14,775 | ₹235 | ₹2,118 | 5.6% |
| FY 2024 | ₹15,302 | ₹268 | ₹2,240 | 12.7% |
| FY 2023 | ₹16,680 | ₹2,317 | ₹3,957 | 17.9% |
| FY 2022 | ₹12,517 | ₹1,258 | ₹2,700 | 12.3% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| TATACHEM ★ | ₹18,325 Cr | 67.30 | 1.87% | -7.68% | 0.36x | -2.01% |
| ATUL | ₹19,303 Cr | 28.49 | 10.45% | 11.53% | 0.03x | 12.07% |
| CHAMBLFERT | ₹19,293 Cr | 9.87 | 19.66% | 20.45% | 0.10x | 5.92% |
| AETHER | ₹18,044 Cr | 83.31 | 11.68% | 9.38% | 0.19x | 21.06% |
| ANURAS | ₹14,458 Cr | 82.62 | 8.65% | 5.76% | 0.40x | 18.15% |
| ACI | ₹6,662 Cr | 61.32 | 6.58% | 5.55% | 0.24x | 6.94% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹37,780 | ₹36,756 | ₹35,084 | ₹33,843 |
| Equity | ₹21,594 | ₹22,241 | ₹19,721 | ₹18,253 |
| Total Debt | ₹7,072 | ₹5,563 | ₹6,296 | ₹7,024 |
| Cash | ₹548 | ₹425 | ₹508 | ₹762 |
| Net Debt | ₹5,756 | ₹4,639 | ₹5,575 | ₹6,040 |
| Working Capital | ₹581 | ₹312 | ₹3,260 | ₹1,649 |
Q3 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q3 FY2026 | 37.98% | 12.26% ↓ | 22.4% ↑ | 27.34% ↑ |
| Q2 FY2026 | 37.98% | 13.73% ↑ | 22.17% ↓ | 26.07% ↓ |
| Q1 FY2026 | 37.98% | 12.85% ↓ | 22.61% ↑ | 26.53% ↓ |
| Q4 FY2025 | 37.98% | 13.29% ↓ | 21.96% ↑ | 26.73% ↑ |
| Q3 FY2025 | 37.98% | 13.6% ↑ | 21.68% ↑ | 26.72% ↓ |
| Q2 FY2025 | 37.98% | 13.56% ↓ | 20.34% ↑ | 28.08% ↓ |
| Q1 FY2025 | 37.98% | 13.76% ↓ | 19.91% ↓ | 28.31% ↑ |
| Q4 FY2024 | 37.98% | 13.84% | 19.97% | 28.18% |
| Ex-Date | Action | Details |
|---|---|---|
| 2026-06-10 | DIVIDEND | Dividend - Rs 11 Per Share |
69 mutual fund schemes
Ask: "Is Tata Chemicals Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Tata Chemicals Ltd is listed on the NSE under the Chemicals sector, Commodity Chemicals industry. ISIN: INE092A01019. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.